No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of palbociclib to adjuvant endocrine therapy does not improve survival in patients with HR⁺, HER2- breast cancer

byTeddy Guo

February 17, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Positive Anti-Spike or Anti-Nucleocapsid Antibody Status is Associated with Reduced Incidence of SARS-CoV-2 Reinfection in Health Care Workers

RelatedReports

Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival

Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026

Majority of pediatric medication-related visits to emergency department are preventable

Oncology

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

January 28, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Admission may not be needed following sleep apnea surgery

Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026

Long-term use of rituximab associated with lower rates of AAV relapse

Avacopan non-inferior to prednisone in the treatment of ANCA-associated vasculitis

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Bimekizumab is tolerable and efficacious for patients with moderate to severe plaque psoriasis

Combined MRI and NIH stroke scores may predict stroke prognosis

Maternal chronic conditions increase risk of cerebral palsy among offspring

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports